6-Shogaol Abrogates Parkinson's Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B

• Main Authors: Misbahuddin Rafeeq (Author), Fahad A. Al-Abbasi (Author), Muhammad Afzal (Author), Ehssan Moglad (Author), Salwa D. Al-Qahtani (Author), Sami I. Alzrea (Author), Naif A. R. Almalki (Author), Faisal Imam (Author), Nadeem Sayyed (Author), Imran Kazmi (Author)
• Format: Book
• Published: MDPI AG, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background/Objectives:</b> 6-Shogaol is a comparatively innovative anti-Parkinson's remedy with antioxidant and anti-inflammatory characteristics. This investigation intended to determine the role of 6-shogaol in the Parkinson's disease (PD) paradigm in rotenone-induced rats...